The list of miracles that have taken place at the French Marian shrine in Lourdes now includes, for the first time, an ...

A Manitoba professor has made leaps and bounds in cancer research, developing a tool that could add years onto multiple myeloma patients' lives.

The feud between Arcellx and Legend Biotech over their anti-BCMA CAR-T therapies for multiple myeloma is getting extra spicy ...

Protara Therapeutics' TARA-002 shows promising early data in bladder cancer, with a 72% complete response rate at 6 months in ...

Three randomized clinical trials, UNITY (Switzerland, Brazil, Argentina), Platinum-CAN (Canada), and EPOXI (EU), are enrolling mpox patients. Given the STOMP and PALM007 results and the design ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/91.IM06wodO.js ...

Stay updated on the latest advancements in bladder cancer treatment and the financial decisions of a leading company in the ...

Near complete exhaustion; negative feelings of being cut off from colleagues; hopelessness; and an inability to complete tasks. These are the telltale signs of burnout, which is on the rise worldwide.

In a retrospective cohort of patients with central nervous system manifestations of multiple myeloma, ide-cel CAR T-cell ...

Developments in chronic lymphocytic leukemia (CLL) this year included the first CAR T-cell therapy approval for the chronic ...

The Archbishop of Liverpool Malcolm McMahon formally recognised the cure of John Traynor during the archdiocese’s first ...

A Phase 3 trial of uproleselan failed to improve overall survival in relapsed/refractory AML, though it may benefit primary ...